Elevation of serum CA 125 and D-dimer levels associated with rupture of ovarian endometrioma

International Journal of Biological Markers

Volumn 22, Issue 3, 2007, Pages 203-205

  Uharcek P ^a   Mlyncek M ^a   Ravinger, J ^a  

^a Faculty Hospital Nitra   (Slovakia)

Author keywords

CA 125; D dimer; Endometriosis; Rupture

Indexed keywords

CA 125 ANTIGEN; D DIMER;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONCENTRATION RESPONSE; CYST RUPTURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECHOGRAPHY; ENDOMETRIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MALIGNANT NEOPLASTIC DISEASE; OVARY CYST; OVARY TUMOR; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL;

EID: 36048956339     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.5668     Document Type: Article

References (17)

1. Gadducci A, Cosio S, Zola P, Landoni F, Maggino T, Sartori E. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer 2007; 17: 21-31.
2. Meden H, Fattahi-Meibodi A. CA 125 in benign gynecological conditions. Int J Biol Markers 1998; 13: 231-7.
3. Molina R, Filella X, Jo J, Agusti C, Ballesta AM. CA 125 in biological fluids. Int J Biol Markers 1998; 13: 224-30.
4. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 2006; 85: 1501-5.
5. Cheng YM, Wang ST, Chou C. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99: 375-80.
6. Redecha M, Korbel M, Borovský M, Chabadovecho J. Tumour marker CA 125 in patients with endometriosis. Prakt Gynekol 2000; 7: 1-6.
7. Moresco RN, Vargas LC, Voegeli CF, Santos RC. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems. J Clin Lab Anal 2003; 17: 77-9.
8. Barbati A, Cosmi EV, Spaziani R, Ventura R, Montanino G. Serum and peritoneal fluid CA-125 levels in patients with endometriosis. Fertil Steril 1994; 61: 438-42.
9. Johansson J, Santala M, Kauppila A. Explosive rise of serum CA 125 following the rupture of ovarian endometrioma. Hum Reprod 1998; 13: 3503-4.
10. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC Jr. CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol 1984; 64: 703-7.
11. Koninckx PR, Muyldermans M, Meuleman C, Cornillie FJ. CA 125 in the management of endometriosis. Eur J Obstet Gynecol Reprod Biol 1993; 49: 109-13.
12. Bon GG, Kenemans P, Dekker JJ, et al. Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles. Hum Reprod 1999; 14: 566-70.
13. Koninckx PR, Muyldermans M, Moerman P, Meuleman C, Deprest J, Cornillie F. CA 125 concentrations in ovarian 'chocolate' cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Hum Reprod 1992; 7: 1314-7.
14. Barbieri RL, Niloff JM, Bast RC Jr, Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986; 45: 630-4.
15. Fujiwara H, Kosaka K, Hamanishi S, et al. Acute elevation of plasma D-dimer levels associated with rupture of an ovarian endometriotic cyst: Case report. Hum Reprod 2003; 18: 338-41.
16. Den Ouden M, Ubachs JM, Stoot JE, Van Wersch JW. Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours. Scand J Clin Lab Invest 1998; 58: 555-9.
17. Gadducci A, Baicchi U, Marrai R, et al. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD) and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type and lymph node status. Gynecol Oncol 1990; 49: 354-8.